{"id":89,"date":"2020-10-27T16:23:38","date_gmt":"2020-10-27T16:23:38","guid":{"rendered":"https:\/\/www.embl.org\/about\/info\/mmpu\/?page_id=89"},"modified":"2026-04-07T11:21:28","modified_gmt":"2026-04-07T11:21:28","slug":"news","status":"publish","type":"page","link":"https:\/\/www.embl.org\/about\/info\/mmpu\/news\/","title":{"rendered":"News"},"content":{"rendered":"\n
\n
\n\n
\n
\n\n

2026<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

<\/h2>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

January 2026
We mourn the passing of Peer Bork.
Peer was one of the pioneer MMPU group leaders. From 2006 to 2020, he led the group Cancer Early Detection<\/a> together with Magnus Knebel Doeberitz, to great successes. He inspired with his brilliance and enthusiasm.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

2025<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

<\/h2>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

October 2025
Matthias Ebert is Spokesperson and Tianzuo Zhan and Michael Zimmermann are PIs in the newly funded DFG Research Unit FOR 5806<\/a> “Functional Genomics and Microbiomics in Precision Medicine of Colorectal Cancer”<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

July 2025
Michael Platten appointed ambassador of the ERC to Germany<\/a>.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

July 2025
MMPU advisor Utz Fischer elected to the EMBO Membership<\/a>.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

July 2025
Michael Platten is co-spokesperson of the new Cluster of Excellence: SynthImmune
Engineering Immune Function with Synthetic Biology<\/a><\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

May 2025
Carsten M\u00fcller-Tidow is spokesperson of the DFG funded new collaborative research center SFB 1709 \u201eCellular Plasticity in Myeloid Malignancies: from Mechanisms to Therapies\u201c<\/a>. <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

April 2025 New Developments at the MMPU<\/p>\n\n\n\n

The MMPU <\/ins>has entered a new phase of leadership. Carsten M\u00fcller-Tidow has been appointed as Co-Director and joins Wolfgang Huber, succeeding the founders Andreas Kulozik and Matthias Hentze, who continue as group leaders within the MMPU. \u201cThe MMPU stands for interdisciplinary collaboration at the highest level. I am honored to contribute to its future as Co-Director,\u201d said Carsten. \u201cThe new co-leadership structure offers an opportunity to further develop the MMPU both organizationally and scientifically. I look forward to working with Carsten and the teams,\u201d added Wolfgang.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

January 2025
The MMPU receives a seminar grant from the Health + Life Science Alliance Heidelberg Mannheim to support the two Public MMPU Research Days 2025. <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

2024<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

<\/h2>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

December 2024
Alba Diz-Mu\u00f1oz selected as Allen Distinguished Investigator and awarded the BINDER Innovation Prize 2024<\/a><\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

November 2024
Matthias Hentze is the 2025 recipient of the Otto Warburg Medal<\/a>, the highest award for biochemists and molecular biologists in Germany<\/a>.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

September 2024
MMPU group leader Eileen Furlong, was elected member of the German National Academy of Sciences Leopoldina<\/a> for her outstanding research in the section \u2018Human Genetics and Molecular Medicine\u2019<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

September 2024
MMPU group leader Mikhail Savitski wins HUPO Discovery in Proteomic Sciences Award<\/a>, recognizing his work on developing Thermal Proteome Profiling (TPP)<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

July 2024
Matias Simons has been awarded the prestigious European Research Council (ERC) Proof-of-Concept Grant for the development of a novel therapy<\/a>.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

April 2024
Rohini Kuner and Michael Platten<\/a>, each receive a prestigious ERC Advanced grant for their ground breaking research<\/a>.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

March 2024
Rohini Kuner is the DFG Gottfried Wilhelm Leibniz Prizewinner<\/a> 2024 in recognition of her pioneering work on the mechanisms underlying chronic pain.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

February 2024
For the second year in a row, the MMPU receives a seminar grant from the Health + Life Science Alliance Heidelberg Mannheim to support the two Public MMPU Research Days 2024. We are very grateful.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

2023<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

<\/h2>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"\/<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

November 2023<\/p>\n\n\n\n

Julio Saez Rodriguez and colleagues receive a prestigious ERC Synergy Grant to study host-microbiome interaction in the gut. The CartoHostBug project <\/a>receives 10 Mio Euro to create \u201cmaps\u201d of the microbial composition and molecular status of human cells at spatially defined locations.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

July 2023
Wolfgang Huber is among 69 life scientists elected to membership<\/a> of the European Molecular Biology Organization (EMBO). Recognised for their contributions to and leadership within the scientific community, they join the organisation\u2019s community of more than 2,000 leading life scientists.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

September 2023
The European Bioconductor Conference<\/a> takes place in September 2023 in Ghent, Belgium, and is co-organised by Wolfgang Huber and colleagues from the Ghent University. The event brings together researchers, developers and users from the Bioconductor Community. <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

June 2023
Wolfgang Huber is organizing the 19th<\/sup> edition of the summer school CSAMA 2023<\/a>, intended for researchers who are interested in making the step from a user of bioinformatics software towards adapting or developing their own analysis workflows.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

24 February 2023
The MMPU receives a seminar grant from the Health + Life Science Alliance Heidelberg Mannheim to support the Public MMPU Research Days 2023. Thank you very much, HLSA!<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

2022<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

<\/h2>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"\/<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

06 April
Matthias Hentze receives the Biochemical Society\u2019s Centenary Award<\/a> for his discoveries in RNA biology. Congratulations Matthias, congratulations to the Hentze team! <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"\/<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

20 March
Judith Zaugg receives ERC Consolidator Grant<\/a> to study interactions between healthy and cancer cells in the human bone marrow. Congratulations Judith, congrats to the Zaugg group and the MMPU group Stem Cell-Niche Networks! <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"
The MMPU is co-directed by Wolfgang Huber (left), Andreas Kulozik (middle) and Matthias Hentze (right).<\/figcaption><\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

01 January
The MMPU is delighted to announce Wolfgang Huber as new co-director of the Molecular Medicine Partnership Unit, taking over this role from Jan Korbel. Wolfgang started in his new role on 1 January 2022.<\/p>\n\n\n\n

Wolfgang joined EMBL in 2004 as a group leader at EMBL-EBI, in 2009 switched to the then newly founded Genome Biology unit in Heidelberg and became EMBL senior scientist in 2011. His interests lie in computational biology and statistical bioinformatics. In 2016, he and his clinician-scientist colleague Sascha Dietrich joined the MMPU with the group Systems Medicine for Cancer Drugs. Their research aims at understanding intra- and inter-patient heterogeneity of response to anti-cancer drugs and using that to improve therapies.<\/p>\n\n\n\n

\n\nRead more<\/summary>\n
\n\n

His expertise in data science complements that of the MMPU co-directors Matthias Hentze and Andreas Kulozik.<\/p>\n\n\n\n

The MMPU warmly thanks Jan Korbel for his four years as co-director of the MMPU. He stepped down from this role at the end of 2021 to enable him to take on additional responsibilities that he has recently accepted. He has strengthened the MMPU with his data science expertise and continues to do so in his role as joint group leader together with Andreas Kulozik of the MMPU group Molecular Pediatric Oncology.<\/p>\n\n\n\n

The MMPU warmly thanks Jan and Wolfgang.<\/p>\n\n\n\n

ABOUT the MMPU: The Molecular Medicine Partnership Unit is a partnership on translational medicine between EMBL and the Heidelberg University Hospital. It has eight research groups with the special set up that each group is headed by at least two group leaders, one from EMBL, and one from the University Hospital, combining expertise in basic science, technology development, biomedical research and clinical translation. The groups use latest experimental and data science technologies to dig into challenging questions in areas including heart and kidney diseases, chronic pain, childhood and adult cancers, blood and iron disorders. With more than 20 nationalities, the MMPU is international and diverse. Over half of its 120 members are women. Training is an important aspect of the MMPU, and it offers training opportunities at all career stages from students, postdocs to established researchers.<\/p>\n\n\n\n

The MMPU started 20 years ago with one research group. It has grown to eight in 2021 and welcomes new groups to join.<\/p>\n\n<\/div>\n<\/details>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

2021 <\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"\/<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

09 December
The MMPU is very proud of its second MMPU group leader after Matthias Hentze in 2000 to receive the Gottfried Wilhelm Leibniz Prize<\/a> 2022. Congratulations Eileen Furlong! <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"\/<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

15 September
Machine learning and multidisciplinary collaboration<\/a> map \u2018constellations\u2019 of molecules, which may help customise medical treatments for blood cancer <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

2020<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"\/<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

23 January
Lifetime Achievement Award for Matthias Hentze. MMPU Co – Director honoured by the international RNA Society<\/a>.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

2019<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

02 April 2019 EMBL etc. Lab Matters
How EMBL partnerships promote collaboration. Read this article about the EMBL Partnership Programme.<\/a> <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n\n
\"\"\/<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

29 April 2019 EMBL NEWS
A newly developed 3D microscope<\/a> visualises fast biological processes better than ever.
Constructing the new microscope was an interdisciplinary effort. The researchers within the two EMBL groups and their collaborators have backgrounds in various scientific fields: the multidisciplinary team comprised physicists, engineers, computer scientists, biologists and a pediatric cardiologist.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

2018<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n
\"\"\/<\/figure>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

October 2018 Press Release EMBL
Ageing is visible in the way cells use glucose<\/a>. A collaboration between clinicians, experimentalists and computational scientists in the Molecular Medicine Partnership Unit (MMPU) unveil the molecular mechanisms of agei <\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n

<\/h2>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n

<\/h2>\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Please visit our News Archive<\/a> page for more news.<\/h3>\n\n<\/div>\n<\/div>\n\n\n
\n
\n\n
\"Official<\/figure>\n\n\n\n
\n \n
\n \n \n

Follow us on <\/strong>Bluesky<\/strong> @mmpu.bsky.social<\/a><\/p>\n <\/div>\n<\/article>\n\n\n\n

<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-title-left-aligned.php","meta":{"_acf_changed":false,"footnotes":""},"embl_taxonomy":[],"class_list":["post-89","page","type-page","status-publish","hentry"],"acf":[],"embl_taxonomy_terms":[],"_links":{"self":[{"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/pages\/89","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/comments?post=89"}],"version-history":[{"count":76,"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/pages\/89\/revisions"}],"predecessor-version":[{"id":17313,"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/pages\/89\/revisions\/17313"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/media?parent=89"}],"wp:term":[{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/mmpu\/wp-json\/wp\/v2\/embl_taxonomy?post=89"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}